James Li is the founder of GondolaBio. GondolaBio has raised $300M in total funding. Latest round: Seed. Based in Palo Alto, California.
James Li is the President of GondolaBio, a clinical-stage biopharmaceutical company focused on developing therapeutics for genetic diseases. He joined the company in August 2024, following its launch as an independent entity from BridgeBio. His role involves leading the company's clinical-stage operations.
Full founder directory · Investor directory · Company funding database · Fundraising library